Trade BioNTech ^BNTX

BioNTech (NASDAQ:BNTX) Price Target Cut to $145.00 by Analysts at HC Wainwright

Groupama Asset Managment Buys 19,994 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Receives Consensus Rating of "Moderate Buy" from Brokerages

BioNTech (NASDAQ:BNTX) Shares Gap Down - Time to Sell?

Analysts' Top Healthcare Picks: Ascentage Pharma Group International Unsponsored ADR (AAPG), BioNTech SE (BNTX) | Markets Insider

Mitsubishi UFJ Trust & Banking Corp Has $21.37 Million Position in BioNTech SE (NASDAQ:BNTX)

CureVac (CVAC) Rises 10% After Key Patent Victory; Other Movers

European Patent Office declares CureVac mRNA patent valid

CureVac (CVAC) Surges as European Court Validates Key Patent

CORRECT: CureVac Says Patent Validated in Dispute With BioNTech

Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts

Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2024 Earnings Call Transcript

Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs

BioNTech SE (NASDAQ:BNTX) Shares Sold by Primecap Management Co. CA

Morgan Stanley Keeps Their Buy Rating on BioNTech SE (BNTX) | Markets Insider

Gallacher Capital Management LLC Sells 159 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech SE (NASDAQ:BNTX) Analysts Just Slashed This Year's Estimates

Vestcor Inc Has $1.13 Million Stake in BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Now Covered by Citigroup

Lbp Am Sa Buys 5,085 Shares of BioNTech SE (NASDAQ:BNTX)

Lbp Am Sa Purchases 5,085 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Citigroup

BioNTech SE (NASDAQ:BNTX) Receives $142.72 Consensus PT from Analysts

This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says

BioNTech initiated with a Buy at Citi | Markets Insider

Amundi Sells 85,658 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech (NASDAQ:BNTX) Trading Down 6.4% Following Analyst Downgrade

BioNTech (NASDAQ:BNTX) Given "Buy" Rating at Canaccord Genuity Group

BMO Capital Markets Issues Positive Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (NASDAQ:BNTX) Issues Quarterly Earnings Results, Beats Estimates By $0.70 EPS

HC Wainwright Predicts BioNTech FY2024 Earnings

BioNTech (BNTX) Expected to Announce Earnings on Wednesday

BioNTech price target lowered to $151 from $172 at Truist | Markets Insider

Goldman Sachs Sticks to Its Buy Rating for BioNTech SE (BNTX) | Markets Insider

BioNTech price target lowered to $110 from $122 at TD Cowen | Markets Insider

BioNTech SE (NASDAQ:BNTX) Q4 2024 Earnings Call Transcript

BioNTech price target raised to $143 from $130 at BMO Capital | Markets Insider

BioNTech Earnings: 2025 Guidance Disappoints, Fair Value Lowered | Morningstar

BioNTech's mRNA Technology and Acquired Oncology Programs Could Support a Future Moat | Morningstar

Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX) and Trevi Therapeutics (TRVI) | Markets Insider

BioNTech price target lowered to $143 from $147 at BofA | Markets Insider

German Court Rules Pfizer, BioNTech Infringed Moderna's COVID-19 Vaccine Patent

BNTX Earnings: BioNTech Stock Slips Despite Q4 Beats | Markets Insider

Morgan Stanley Remains a Buy on BioNTech SE (BNTX) | Markets Insider

BioNTech (NASDAQ:BNTX) Releases Earnings Results, Beats Expectations By $0.70 EPS

BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update | The Manila Times

BioNTech reports Q4 EPS EUR 1.08 vs. EUR 1.88 last year | Markets Insider

BioNTech sees FY25 CapEx EUR 250M-EUR 350M | Markets Insider

BioNTech sees FY25 revenue EUR 1.7B-EUR 2.2B | Markets Insider

1,200 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by Generali Investments CEE investicni spolecnost a.s.

BioNTech Warns On FY25 Revenues After Weak Q4; Stock Dips

BioNTech SE Q4 Income Retreats, But Beats Estimates

Amended: BioNTech SE Q4 Income Declines

BioNTech SE Q4 24 Earnings Conference Call At 8:00 AM ET

2,415 Shares in BioNTech SE (NASDAQ:BNTX) Purchased by QRG Capital Management Inc.

BioNTech SE (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

The Zacks Analyst Blog Jazz Pharmaceuticals, Chimerix, Moderna, GSK and Regeneron Pharmaceuticals

Candriam S.C.A. Sells 80,230 Shares of BioNTech SE (NASDAQ:BNTX)

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday

Berenberg Bank Sticks to Its Buy Rating for BioNTech SE (BNTX) | Markets Insider

Here's Why Moderna Stock Soared 16% on Wednesday - March 6, 2025 - Zacks.com

Moderna mRNA Vaccine Technology Patents Invalidated by Tribunal

Moderna mRNA Vaccine Tech Patents Invalidated by Tribunal (1)

Why Moderna (MRNA) Stock Is Rallying Today

Pfizer and BioNTech violated Moderna's Covid-19 vaccine patent, German court rules

German Court Rules Pfizer, BioNTech, Violated Moderna Covid-19 Vaccine Patent, Reuters Reports | Morningstar

German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent

SBI Securities Co. Ltd. Purchases Shares of 3,429 BioNTech SE (NASDAQ:BNTX)

U.S. FDA places BioNTech's malaria vaccine study on clinical hold

US FDA places BioNTech's malaria vaccine study on clinical hold

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial